<SEC-DOCUMENT>0000950170-25-044432.txt : 20250325
<SEC-HEADER>0000950170-25-044432.hdr.sgml : 20250325
<ACCEPTANCE-DATETIME>20250325162750
ACCESSION NUMBER:		0000950170-25-044432
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		17
FILED AS OF DATE:		20250325
DATE AS OF CHANGE:		20250325
EFFECTIVENESS DATE:		20250325

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AN2 Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001880438
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				820606654
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-286094
		FILM NUMBER:		25768688

	BUSINESS ADDRESS:	
		STREET 1:		1800 EL CAMINO REAL, SUITE D
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94027
		BUSINESS PHONE:		(650) 331-9090

	MAIL ADDRESS:	
		STREET 1:		1800 EL CAMINO REAL, SUITE D
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94027
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>antx-20250325.htm
<DESCRIPTION>S-8
<TEXT>
<html>
 <head>
  <title>S-8</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">As filed with the Securities and Exchange Commission on March 25, 2025<br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Registration No. 333-</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">      </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">      </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:3pt;font-family:Arial;font-kerning:none;min-width:fit-content;">___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:3pt;font-family:Arial;font-kerning:none;min-width:fit-content;">___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________</font></p>
  <p style="font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">UNITED STATES</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Washington, D.C. 20549</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:3pt;font-family:Arial;font-kerning:none;min-width:fit-content;">________________________________________________________________________________________</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">FORM S-8</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">REGISTRATION STATEMENT</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">UNDER</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">THE SECURITIES ACT OF 1933</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:3pt;font-family:Arial;font-kerning:none;min-width:fit-content;">________________________________________________________________________________________</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:26pt;font-family:Arial;font-kerning:none;min-width:fit-content;">AN2 Therapeutics, Inc.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">(Exact name of registrant as specified in its charter)</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:3pt;font-family:Arial;font-kerning:none;min-width:fit-content;">________________________________________________________________________________________</font></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:50.52%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:48.48%;box-sizing:content-box;"></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:11pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">82-0606654</font></p></td>
   </tr>
   <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">(State or other jurisdiction of<br>incorporation or organization)</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">(I.R.S. Employer<br>Identification No.)</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">1800 El Camino Real, Suite D</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Menlo Park, California 94027</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">(Address of principal executive offices) (Zip code)</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">AN2 Therapeutics, Inc. 2022 Equity Incentive Plan</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">AN2 Therapeutics, Inc. 2022 Employee Stock Purchase Plan</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">(Full titles of the plans)</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Eric Easom</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Chief Executive Officer</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">AN2 Therapeutics, Inc.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">1800 El Camino Real, Suite D</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Menlo Park, California 94027</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">(650) 331-9090</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">(Name and address of agent for service) (Telephone number, including area code, of agent for service)</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:3pt;font-family:Arial;font-kerning:none;min-width:fit-content;">________________________________________________________________________________________</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Copies to:</font></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:50.48%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:48.52%;box-sizing:content-box;"></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Kathleen M. Wells<br>Richard Kim<br>Latham &amp; Watkins LLP<br>140 Scott Drive<br>Menlo Park, California 94025<br>(650) 328-4600</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Lucy O. Day</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">AN2 Therapeutics, Inc.<br>1800 El Camino Real, Suite D</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Menlo Park, California 94027</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">(650) 331-9090</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:3pt;font-family:Arial;font-kerning:none;min-width:fit-content;">________________________________________________________________________________________</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#x201c;large accelerated filer,&#x201d; &#x201c;accelerated filer,&#x201d; &#x201c;smaller reporting company,&#x201d; and &#x201c;emerging growth company&#x201d; in Rule 12b-2 of the Exchange Act.</font></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:18.996%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:52.949%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:23.115%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:1.94%;box-sizing:content-box;"></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Large accelerated filer</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#9744;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Accelerated filer</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#9744;</font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Non-accelerated filer</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#9746;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Smaller reporting company</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#9746;</font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Emerging growth company</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#9746;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.  &#9744;</font></p>
  <p style="font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:3pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:3pt;font-family:Arial;font-kerning:none;min-width:fit-content;">___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________<br>___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:3pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">EXPLANATORY NOTE</font></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">REGISTRATION OF ADDITIONAL SHARES</font></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Pursuant to General Instruction E of Form S-8, AN2 Therapeutics, Inc. (the &#x201c;Registrant&#x201d;) is filing this Registration Statement on Form S-8 with the Securities and Exchange Commission (the &#x201c;Commission&#x201d;) for the purpose of registering (i) 1,196,785 additional shares of its Common Stock, par value $0.00001 per share (&#x201c;Common Stock&#x201d;), under the 2022 Equity Incentive Plan (the &#x201c;2022 Plan&#x201d;), pursuant to the provisions of the 2022 Plan providing for an automatic increase in the number of shares of Common Stock reserved and available for issuance under the 2022 Plan on January 1, 2025, and (ii) 299,196 additional shares of its Common Stock under the 2022 Employee Stock Purchase Plan (the &#x201c;2022 ESPP,&#x201d; together with the 2022 Plan, the &#x201c;Plans&#x201d;), pursuant to the provisions of the 2022 ESPP providing for an automatic increase in the number of shares of Common Stock reserved and available for issuance under the 2022 ESPP on January 1, 2025. In accordance with the instructional note to Part I of Form S-8 as promulgated by the Commission, the information specified by Part I of the Form S-8 has been omitted from this Registration Statement.</font></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The Registrant previously registered shares of its Common Stock for issuance under the Plans on a Registration Statement on Form S-8 filed with the Commission on March 29, 2022 (</font><a href="https://www.sec.gov/Archives/edgar/data/1880438/000119312522086928/d302229ds8.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">File No. 333-263917</font></a><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">), a Registration Statement on Form S-8 filed with the Commission on March 30, 2023 (</font><a href="https://www.sec.gov/Archives/edgar/data/1880438/000119312523084122/d492464ds8.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">File No. 333-270962</font></a><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">), and a Registration Statement on Form S-8 filed with the Commission on March 29, 2024 (</font><a href="https://www.sec.gov/Archives/edgar/data/1880438/000095017024038752/antx-s8-q124.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">File No. 333-278399</font></a><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">). Pursuant to General Instruction E to Form S-8, this Registration Statement hereby incorporates by reference the contents of the Registration Statements referenced above except as set forth below.</font></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:24pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">PART II</font></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">INFORMATION REQUIRED IN REGISTRATION STATEMENT</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE</font></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The following documents filed by the Registrant with the Commission are incorporated by reference into this Registration Statement:</font></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">(a) The Registrant&#x2019;s </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001880438/000095017025044366/antx-20241231.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Annual Report on Form 10-K</font></a><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> for the fiscal year ended December 31, 2024, filed with the Commission on March 25, 2025.</font></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">(b) The description of the Registrant&#x2019;s Common Stock which is contained in the Registrant&#x2019;s Registration Statement on Form 8-A filed on March 22, 2022 (</font><a href="https://www.sec.gov/Archives/edgar/data/1880438/000119312522081697/d338356d8a12b.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">File No. 001-41331</font></a><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">) under the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;), as updated by </font><a href="https://www.sec.gov/Archives/edgar/data/1880438/000095017023010627/antx-ex4_3.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit 4.3</font></a><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> to the Registrant&#x2019;s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the Commission on March 29, 2023, including any amendment or report filed for the purpose of updating such description.</font></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">(c) The description of rights to purchase Series A Junior Participating Preferred Stock contained in the Registrant&#x2019;s Registration Statement on Form 8-A filed with the Commission on August 19, 2024, including any amendment or report filed for the purpose of updating such description.</font></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">(d) All other reports and documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14, and 15(d) of the Exchange Act (other than Current Reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits furnished on such form that relate to such items) on or after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part of this Registration Statement from the date of the filing of such reports and documents. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document that also is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">ITEM 8. EXHIBITS</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:9%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:44.5%;box-sizing:content-box;"></td>
    <td style="width:1.1%;box-sizing:content-box;"></td>
    <td style="width:6%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:12%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:9%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:14.4%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td colspan="7" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Incorporated by Reference</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Number</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Description</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Form</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">File No.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Filing Date</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">4.1</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1880438/000119312524166938/d860451dex31.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-family:Arial;font-kerning:none;min-width:fit-content;">Amended and Restated Certificate of Incorporation of the Registrant.</font></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">8-K</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">001-41331</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">3.1</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">June 24, 2024</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">4.2</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1880438/000119312522066048/d211954dex34.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-family:Arial;font-kerning:none;min-width:fit-content;">Amended and Restated Bylaws of the Registrant.</font></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">S-1</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">333-263295</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">3.4</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">March 4, 2022</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">4.3</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1880438/000119312522080012/d211954dex41.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-family:Arial;font-kerning:none;min-width:fit-content;">Form of Common Stock Certificate of the Registrant.</font></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">S-1</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">333-263295</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">4.1</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">March 21, 2022</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">4.4</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1880438/000119312524202430/d879523dex41.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-family:Arial;font-kerning:none;min-width:fit-content;">Rights Agreement, dated as of August 15, 2024, between AN2 Therapeutics, Inc. and Equiniti Trust Company, LLC, which includes the Form of Certificate of Designations of Series A Junior Participating Preferred Stock as Exhibit A, the Form of Right Certificate as Exhibit B and the Summary of Rights to Purchase Preferred Stock as Exhibit C.</font></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">8-K</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">001-41331</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">4.1</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">August 19, 2024</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">4.5</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1880438/000119312524202430/d879523dex31.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-family:Arial;font-kerning:none;min-width:fit-content;">Certificate of Designations of Series A Junior Participating Preferred Stock of AN2 Therapeutics, Inc. filed with the Secretary of State of the State of Delaware on August 15, 2024.</font></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">8-K</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">001-41331</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">3.1</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">August 19, 2024</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">5.1*</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="antx-ex5_1.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-family:Arial;font-kerning:none;min-width:fit-content;">Opinion of Latham &amp; Watkins LLP.</font></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">23.1*</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="antx-ex5_1.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-family:Arial;font-kerning:none;min-width:fit-content;">Consent of Latham &amp; Watkins LLP (included in Exhibit 5.1).</font></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">23.2*</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="antx-ex23_2.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-family:Arial;font-kerning:none;min-width:fit-content;">Consent of Independent Registered Public Accounting Firm.</font></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">24.1*</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#poa"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-family:Arial;font-kerning:none;min-width:fit-content;">Power of Attorney (included on the signature page of this Registration Statement).</font></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">99.1</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;font-family:Arial;position:relative;font-kerning:none;min-width:fit-content;">#</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1880438/000095017024038681/antx-ex10_3.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-family:Arial;font-kerning:none;min-width:fit-content;">AN2 Therapeutics, Inc. 2022 Equity Incentive Plan.</font></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">10-K</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">001-41331</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">10.3</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">March 29, 2024</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">99.2</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;font-family:Arial;position:relative;font-kerning:none;min-width:fit-content;">#</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1880438/000119312522066048/d211954dex104.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-family:Arial;font-kerning:none;min-width:fit-content;">Forms of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the AN2 Therapeutics, Inc. 2022 Equity Incentive Plan.</font></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">S-1</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">333-263295</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">10.4</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">March 4, 2022</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">99.3</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;font-family:Arial;position:relative;font-kerning:none;min-width:fit-content;">#</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1880438/000119312522066048/d211954dex105.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-family:Arial;font-kerning:none;min-width:fit-content;">Form of Restricted Stock Unit Grant Notice and Award Agreement under the AN2 Therapeutics, Inc. 2022 Equity Incentive Plan.</font></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">10-K</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">001-41331</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">10.5</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">March 29, 2024</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">99.4</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;font-family:Arial;position:relative;font-kerning:none;min-width:fit-content;">#</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1880438/000095017024038681/antx-ex10_6.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-family:Arial;font-kerning:none;min-width:fit-content;">AN2 Therapeutics, Inc. 2022 Employee Stock Purchase Plan.</font></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">10-K</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">001-41331</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">10.6</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">March 29, 2024</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">107.1*</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="antx_exfilingfees.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-family:Arial;font-kerning:none;min-width:fit-content;">Filing Fee Table.</font></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:3pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:3pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:3pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:3pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:3pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:3pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:3pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:3pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:3pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:3pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:3pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">* Filed herewith.<br></font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Arial;font-kerning:none;min-width:fit-content;">#</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> Indicates management contract or compensatory plan.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">SIGNATURES</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Menlo Park, State of California, on March 25, 2025.</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:41.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:8.24%;box-sizing:content-box;"></td>
    <td style="width:2.424%;box-sizing:content-box;"></td>
    <td style="width:89.336%;box-sizing:content-box;"></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">AN2 THERAPEUTICS, INC.</font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.75pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.75pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">/s/ Eric Easom</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Eric Easom</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">President and Chief Executive Officer</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="poa"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">POWER OF ATTORNEY</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Eric Easom and Lucy O. Day, and each of them, as his or her true and lawful attorneys-in-fact and agents, each with the full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Registration Statement (including post-effective amendments), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.<br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:33%;box-sizing:content-box;"></td>
    <td style="width:1.04%;box-sizing:content-box;"></td>
    <td style="width:43.3%;box-sizing:content-box;"></td>
    <td style="width:1.04%;box-sizing:content-box;"></td>
    <td style="width:21.62%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Signature</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Title</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Date</font></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">/s/ Eric Easom</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Chief Executive Officer and Board Chair<br>(Principal Executive Officer)</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">March 25, 2025</font></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Eric Easom</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">/s/ Lucy O. Day</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Chief Financial Officer</font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(Principal Financial Officer and Principal Accounting Officer)</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">March 25, 2025</font></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Lucy O. Day</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">/s/ Joseph Zakrzewski</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Director</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">March 25, 2025</font></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Joseph Zakrzewski</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">/s/ Kabeer Aziz</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Director</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">March 25, 2025</font></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Kabeer Aziz</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">/s/ Maggie FitzPatrick</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Lead Independent Director</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">March 25, 2025</font></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Maggie FItzPatrick</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">/s/ Gilbert L. Marks</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Director</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">March 25, 2025</font></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Gilbert L. Marks</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">/s/ Patricia (Patty) Martin</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Director</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">March 25, 2025</font></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Patricia (Patty) Martin</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">/s/ Rob Readnour</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Director</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">March 25, 2025</font></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Rob Readnour</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">/s/ Melvin Spigelman</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Director</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">March 25, 2025</font></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Melvin Spigelman</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">/s/ Stephanie Wong</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Director</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">March 25, 2025</font></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Stephanie Wong</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>antx-ex5_1.htm
<DESCRIPTION>EX-5.1
<TEXT>
<html>
 <head>
  <title>EX-5.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.38in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img51266987_0.jpg" alt="img51266987_0.jpg" style="width:237px;height:16px;"></p>
  <p style="margin-left:60%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:Arial;font-kerning:none;min-width:fit-content;">140 Scott Drive</font></p>
  <p style="margin-left:60%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Menlo Park, California  94025</font></p>
  <p style="margin-left:60%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Tel: +1.650.328.4600  Fax: +1.650.463.2600</font></p>
  <p style="margin-left:53.333%;text-indent:14.286%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:5.75pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:Arial;font-kerning:none;min-width:fit-content;">www.lw.com</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 25, 2025</font></p>
  <p style="margin-left:60%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:Arial;font-kerning:none;min-width:fit-content;">FIRM / AFFILIATE OFFICES</font></p>
  <p style="margin-left:53.333%;text-indent:14.286%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Austin		Milan</font></p>
  <p style="margin-left:53.333%;text-indent:14.286%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Beijing		Munich</font></p>
  <p style="margin-left:53.333%;text-indent:14.286%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Boston		New York</font></p>
  <p style="margin-left:53.333%;text-indent:14.286%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Brussels		Orange County</font></p>
  <p style="margin-left:53.333%;text-indent:14.286%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Century City	Paris</font></p>
  <p style="margin-left:53.333%;text-indent:14.286%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Chicago		Riyadh</font></p>
  <p style="margin-left:53.333%;text-indent:14.286%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Dubai		San Diego</font></p>
  <p style="margin-left:53.333%;text-indent:14.286%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:Arial;font-kerning:none;min-width:fit-content;">D&uuml;sseldorf		San Francisco</font></p>
  <p style="margin-left:53.333%;text-indent:14.286%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Frankfurt		Seoul</font></p>
  <p style="margin-left:53.333%;text-indent:14.286%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Hamburg		Silicon Valley</font></p>
  <p style="margin-left:53.333%;text-indent:14.286%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Hong Kong		Singapore</font></p>
  <p style="margin-left:60%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Houston		Tel Aviv</font></p>
  <p style="margin-left:53.333%;text-indent:14.286%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:Arial;font-kerning:none;min-width:fit-content;">London		Tokyo</font></p>
  <p style="margin-left:60%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Los Angeles	Washington, D.C.</font></p>
  <p style="margin-left:53.333%;text-indent:14.286%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Madrid	</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AN2 Therapeutics, Inc.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1800 El Camino Real, Suite D</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Menlo Park, California 94027</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Re: 	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registration Statement on Form S-8</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">		</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To the addressee set forth above:</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have acted as special counsel to AN2 Therapeutics, Inc., a Delaware corporation (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), in connection with the registration by the Company of an aggregate of 1,495,532 shares of Common Stock of the Company, par value $0.00001 per share (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), issuable under the Company&#x2019;s 2022 Equity Incentive Plan (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2022 Plan</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) and 2022 Employee Stock Purchase Plan (together with the 2022 Plan, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Plans</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), and associated preferred stock purchase rights (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Rights</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) to be issued pursuant to the Rights Agreement dated as of August 15, 2024, between the Company and Equiniti Trust Company, LLC, as rights agent (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Rights Agent</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Shares and associated Rights are included in a registration statement on Form S-8 under the Securities Act of 1933, as amended (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Securities Act</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), filed with the Securities and Exchange Commission (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Commission</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) on March 25, 2025 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Registration Statement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement or related prospectus, other than as expressly stated herein with respect to the issuance of the Shares and the associated Rights.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As such counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this letter. With your consent, we have relied upon certificates and other assurances of officers of the Company and others as to factual matters without having independently verified such factual matters. We are opining herein as to the</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.38in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">||</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.38in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;">
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:27.35pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">March 25, 2025</font></p><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">2</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:5.65pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><img src="img51266987_1.jpg" alt="img51266987_1.jpg" style="width:163px;height:11px;"></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General Corporation Law of the State of Delaware (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">DGCL</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), and we express no opinion with respect to any other laws.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Subject to the foregoing and the other matters set forth herein, it is our opinion that, as of the date hereof, when the Shares shall have been duly registered on the books of the transfer agent and registrar therefor in the name or on behalf of the purchasers, or certificates representing the Shares have been manually signed by an authorized officer of the transfer agent and registrar therefor, and have been issued by the Company for legal consideration of not less than par value in the circumstances contemplated by the applicable Plan and the Rights Agreement, assuming in each case that the individual issuances, grants or awards under the applicable Plan and the Rights Agreement are duly authorized by all necessary corporate action and duly issued, granted or awarded and exercised in accordance with the requirements of law, the applicable Plan (and the agreements and awards duly adopted thereunder and in accordance therewith) and the Rights Agreement, the issuance and sale of the Shares and associated Rights will have been duly authorized by all necessary corporate action of the Company, and the Shares and associated Rights will be validly issued, and the Shares will be fully paid and non-assessable. In rendering the foregoing opinion, we have assumed that the Company will comply with all applicable notice requirements regarding uncertificated shares provided in the DGCL.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This letter assumes, with your consent, that the Board of Directors of the Company has acted in accordance with its fiduciary duties in adopting the Rights Agreement, and does not address whether the Board of Directors may be required to redeem or terminate, or take other action with respect to, the Rights in the future based on the facts and circumstances then existing. Moreover, this letter addresses corporate procedures in connection with the issuance of the Rights associated with the Shares, and not any particular provision of the Rights or the Rights Agreement. It should be understood that it is not settled whether the invalidity of any particular provision of a rights agreement or of rights issued thereunder would result in invalidating in their entirety such rights.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This opinion is for your benefit in connection with the Registration Statement and may be relied upon by you and by persons entitled to rely upon it pursuant to the applicable provisions of the Securities Act. We consent to your filing this opinion as an exhibit to the Registration Statement. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission thereunder.</font></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sincerely, <br><br>  /s/ Latham &amp; Watkins LLP</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.38in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>antx-ex23_2.htm
<DESCRIPTION>EX-23.2
<TEXT>
<html>
 <head>
  <title>EX-23.2</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit 23.2</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of AN2 Therapeutics, Inc. of our report dated March 25, 2025 relating to the financial statements, which appears in AN2 Therapeutics, Inc.&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2024.</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <table style="border-spacing:0;table-layout:auto;width:40.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;box-sizing:content-box;"></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">/s/ PricewaterhouseCoopers LLP</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">San Jose, California</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">March 25, 2025</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>antx_exfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-03-25T16:24:55.7128+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:antx="http://www.an2therapeutics.com/20250325" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>EX-FILING FEES</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_f3ca39c5-a237-4c27-aac5-b6c721d1dabc" name="ffd:FeeExhibitTp" contextRef="C_aeae6f8e-7bd1-4f27-8e53-c9f1212753ea">EX-FILING FEES</ix:nonNumeric><ix:nonNumeric id="F_a1ca55e2-2c14-4d77-a29f-afb7009ec5d3" name="dei:EntityCentralIndexKey" contextRef="C_aeae6f8e-7bd1-4f27-8e53-c9f1212753ea">0001880438</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"/></ix:references><ix:resources><xbrli:context id="C_aeae6f8e-7bd1-4f27-8e53-c9f1212753ea"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001880438</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-25</xbrli:startDate><xbrli:endDate>2025-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_24f95288-ebb5-4f77-8b9e-c8566295825f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001880438</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>2</dei:lineNo></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-25</xbrli:startDate><xbrli:endDate>2025-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7c0d364f-6ff9-440f-8ce9-ccdd5b0de136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001880438</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-25</xbrli:startDate><xbrli:endDate>2025-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="U_pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U_shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U_USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit></ix:resources></ix:header></div>
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit 107.1</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">CALCULATION OF FILING FEE TABLE</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Form </span><span style="font-size:10pt;font-family:Arial;"><ix:nonNumeric id="F_14de71ab-2c53-4ee1-bbe1-eff6ea70aed1" contextRef="C_aeae6f8e-7bd1-4f27-8e53-c9f1212753ea" name="ffd:FormTp"><ix:nonNumeric id="F_770b0d85-33b6-45c6-bf71-399aaaf4f8ed" contextRef="C_aeae6f8e-7bd1-4f27-8e53-c9f1212753ea" name="ffd:SubmissnTp"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">S-8</span></ix:nonNumeric></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:10pt;font-family:Arial;"><ix:nonNumeric id="F_09b194a9-ef76-474e-9f42-deab474b8f76" contextRef="C_aeae6f8e-7bd1-4f27-8e53-c9f1212753ea" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">AN2 Therapeutics, Inc.</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Table 1: Newly Registered Securities</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></p>
  <table style="border-spacing:0;table-layout:auto;width:99.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:8.081%;box-sizing:content-box;"/>
    <td style="width:1.01%;box-sizing:content-box;"/>
    <td style="width:19.192%;box-sizing:content-box;"/>
    <td style="width:1.01%;box-sizing:content-box;"/>
    <td style="width:11.111%;box-sizing:content-box;"/>
    <td style="width:1.01%;box-sizing:content-box;"/>
    <td style="width:12.121%;box-sizing:content-box;"/>
    <td style="width:1.01%;box-sizing:content-box;"/>
    <td style="width:9.091%;box-sizing:content-box;"/>
    <td style="width:1.01%;box-sizing:content-box;"/>
    <td style="width:13.131%;box-sizing:content-box;"/>
    <td style="width:1.01%;box-sizing:content-box;"/>
    <td style="width:10.101%;box-sizing:content-box;"/>
    <td style="width:1.01%;box-sizing:content-box;"/>
    <td style="width:10.101%;box-sizing:content-box;"/>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-right:0.75pt solid #000000;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;font-family:Arial;"><ix:nonNumeric id="F_3328d499-745e-4965-bb1c-b9906e3e41ea" contextRef="C_7c0d364f-6ff9-440f-8ce9-ccdd5b0de136" name="ffd:PrevslyPdFlg" format="ixt:fixed-false"><ix:nonNumeric id="F_cdd1c862-e7ec-45aa-82ed-166c1dfb2c8b" contextRef="C_24f95288-ebb5-4f77-8b9e-c8566295825f" name="ffd:PrevslyPdFlg" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Security Type</span></ix:nonNumeric></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Security</span></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Title</span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Fee<br/>Calculation<br/>Rule</span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Amount to be<br/>Registered </span><span style="color:#000000;top:-4.221pt;white-space:pre-wrap;font-weight:bold;font-size:6.03pt;font-family:Arial;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Proposed<br/>Maximum<br/>Offering<br/>Price Per<br/>Share</span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Proposed<br/>Maximum<br/>Aggregate<br/>Offering<br/>Price</span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Fee<br/>Rate</span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.75pt solid #000000;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Amount of<br/>Registration<br/>Fee</span></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-right:0.75pt solid #000000;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-family:Arial;"><ix:nonNumeric id="F_f8d4bbc0-a4da-4957-b412-69e0606d07e1" contextRef="C_7c0d364f-6ff9-440f-8ce9-ccdd5b0de136" name="ffd:OfferingSctyTp"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-family:Arial;"><ix:nonNumeric id="F_50da937c-a949-4f67-974a-55b02275786f" contextRef="C_7c0d364f-6ff9-440f-8ce9-ccdd5b0de136" name="ffd:OfferingSctyTitl"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common Stock, $0.00001 par value per share, reserved for issuance pursuant to the Registrant's 2022 Equity Incentive Plan, together with the associated Series A Junior Participating Preferred Stock Purchase Rights</span></ix:nonNumeric></span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;font-family:Arial;position:relative;font-kerning:none;min-width:fit-content;">(6)</span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-family:Arial;"><ix:nonNumeric id="F_f1bcf6c3-770a-4cea-9ef3-3acb91cfe6cc" contextRef="C_7c0d364f-6ff9-440f-8ce9-ccdd5b0de136" name="ffd:FeesOthrRuleFlg" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">457(c) and 457(h)</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-family:Arial;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b0af3dce-461c-4279-99c4-21dbc1714536" contextRef="C_7c0d364f-6ff9-440f-8ce9-ccdd5b0de136" name="ffd:AmtSctiesRegd" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">1,196,785</ix:nonFraction></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;font-family:Arial;position:relative;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">$</span><span style="font-family:Arial;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8372978f-9194-4ace-bf28-4a5abf7d2843" contextRef="C_7c0d364f-6ff9-440f-8ce9-ccdd5b0de136" name="ffd:MaxOfferingPricPerScty" unitRef="U_USD" scale="0" decimals="2" format="ixt:num-dot-decimal">1.39</ix:nonFraction></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;font-family:Arial;position:relative;font-kerning:none;min-width:fit-content;">(4)</span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">$</span><span style="font-family:Arial;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9d1a46f9-5744-4ecb-8231-d6d48e1823ea" contextRef="C_7c0d364f-6ff9-440f-8ce9-ccdd5b0de136" name="ffd:MaxAggtOfferingPric" unitRef="U_USD" scale="0" decimals="2" format="ixt:num-dot-decimal">1,663,531.15</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-family:Arial;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cb14a41d-ff4f-4b21-a0d9-da0c3dbf4368" contextRef="C_7c0d364f-6ff9-440f-8ce9-ccdd5b0de136" name="ffd:FeeRate" unitRef="U_pure" scale="0" decimals="7" format="ixt:num-dot-decimal">0.0001531</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">$</span><span style="font-family:Arial;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b5e1cd74-d330-49aa-8d45-27b92227c476" contextRef="C_7c0d364f-6ff9-440f-8ce9-ccdd5b0de136" name="ffd:FeeAmt" unitRef="U_USD" scale="0" decimals="2" format="ixt:num-dot-decimal">254.69</ix:nonFraction></span></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-right:0.75pt solid #000000;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-family:Arial;"><ix:nonNumeric id="F_96c88e93-68ed-40f8-93a7-cd94e78c781b" contextRef="C_24f95288-ebb5-4f77-8b9e-c8566295825f" name="ffd:OfferingSctyTp"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-family:Arial;"><ix:nonNumeric id="F_710b6d4d-6d5e-435c-b18d-09bc2e7b7ae2" contextRef="C_24f95288-ebb5-4f77-8b9e-c8566295825f" name="ffd:OfferingSctyTitl"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common Stock, $0.00001 par value per share, reserved for future issuance pursuant to the Registrant's 2022 Employee Stock Purchase Plan, together with the associated Series A Junior Participating Preferred Stock Purchase Rights</span></ix:nonNumeric></span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;font-family:Arial;position:relative;font-kerning:none;min-width:fit-content;">(6)</span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-family:Arial;"><ix:nonNumeric id="F_8a8185c5-1281-45e6-a23b-014e19c118f5" contextRef="C_24f95288-ebb5-4f77-8b9e-c8566295825f" name="ffd:FeesOthrRuleFlg" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">457(c) and 457(h)</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-family:Arial;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_417ce742-dc76-4e05-8c55-c7f87b74dd83" contextRef="C_24f95288-ebb5-4f77-8b9e-c8566295825f" name="ffd:AmtSctiesRegd" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">299,196</ix:nonFraction></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;font-family:Arial;position:relative;font-kerning:none;min-width:fit-content;">(3)</span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">$</span><span style="font-family:Arial;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cbfa6098-cd4b-4824-8167-d70df77cfffe" contextRef="C_24f95288-ebb5-4f77-8b9e-c8566295825f" name="ffd:MaxOfferingPricPerScty" unitRef="U_USD" scale="0" decimals="2" format="ixt:num-dot-decimal">1.18</ix:nonFraction></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;font-family:Arial;position:relative;font-kerning:none;min-width:fit-content;">(5)</span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">$</span><span style="font-family:Arial;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2458f3e6-5713-4a5c-b925-97eff79fb72b" contextRef="C_24f95288-ebb5-4f77-8b9e-c8566295825f" name="ffd:MaxAggtOfferingPric" unitRef="U_USD" scale="0" decimals="2" format="ixt:num-dot-decimal">353,051.28</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-family:Arial;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_32983a2d-0a55-4b32-8520-2260128f0cfe" contextRef="C_24f95288-ebb5-4f77-8b9e-c8566295825f" name="ffd:FeeRate" unitRef="U_pure" scale="0" decimals="7" format="ixt:num-dot-decimal">0.0001531</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">$</span><span style="font-family:Arial;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_74e297a7-fa49-465d-8abf-e7fa7e2a86cd" contextRef="C_24f95288-ebb5-4f77-8b9e-c8566295825f" name="ffd:FeeAmt" unitRef="U_USD" scale="0" decimals="2" format="ixt:num-dot-decimal">54.05</ix:nonFraction></span></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="7" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-right:0.75pt solid #000000;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="7" style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Total Offering Amounts</span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">$</span><span style="font-family:Arial;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e428ffce-3131-49bc-b082-f37ef2993c68" contextRef="C_aeae6f8e-7bd1-4f27-8e53-c9f1212753ea" name="ffd:TtlOfferingAmt" unitRef="U_USD" scale="0" decimals="2" format="ixt:num-dot-decimal">2,016,582.43</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">$</span><span style="font-family:Arial;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7341a95d-f539-42b3-b966-580dd7fbb2c6" contextRef="C_aeae6f8e-7bd1-4f27-8e53-c9f1212753ea" name="ffd:TtlFeeAmt" unitRef="U_USD" scale="0" decimals="2" format="ixt:num-dot-decimal">308.74</ix:nonFraction></span></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="7" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-right:0.75pt solid #000000;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="7" style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Total Fee Offsets</span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="7" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.75pt solid #000000;padding-top:0.01in;border-right:0.75pt solid #000000;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="7" style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;border-bottom:0.75pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Net Fee Due</span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;border-bottom:0.75pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.75pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;border-bottom:0.75pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.75pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;border-bottom:0.75pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.75pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-left:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;border-bottom:0.75pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.75pt solid #000000;vertical-align:top;padding-bottom:0in;border-bottom:0.75pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">$</span><span style="font-family:Arial;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_69c2e79e-9344-47c2-804b-42b67d176b78" contextRef="C_aeae6f8e-7bd1-4f27-8e53-c9f1212753ea" name="ffd:NetFeeAmt" unitRef="U_USD" scale="0" decimals="2" format="ixt:num-dot-decimal">308.74</ix:nonFraction></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"><br/></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10pt;font-family:Arial;"><ix:nonNumeric id="F_f0bef5c5-bc81-4358-8e44-e3b1d3f430bf" contextRef="C_7c0d364f-6ff9-440f-8ce9-ccdd5b0de136" name="ffd:OfferingNote" escape="true" continuedAt="F_f0bef5c5-bc81-4358-8e44-e3b1d3f430bf_1"><div><ix:nonNumeric id="F_6b2582e7-67ce-4e0d-9389-232d0941d60e" contextRef="C_24f95288-ebb5-4f77-8b9e-c8566295825f" name="ffd:OfferingNote" escape="true" continuedAt="F_6b2582e7-67ce-4e0d-9389-232d0941d60e_1"><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this Registration Statement shall also cover any additional shares of Common Stock (&#8220;Common Stock&#8221;) of AN2 Therapeutics, Inc. (the &#8220;Registrant&#8221;) that become issuable under the Registrant&#8217;s 2022 Equity Incentive Plan (the &#8220;2022 Plan&#8221;) and the Registrant&#8217;s 2022 Employee Stock Purchase Plan (the &#8220;2022 ESPP&#8221;) by reason of any stock dividend, stock split, recapitalizations, or other similar transaction effected without receipt of consideration that results in an increase to the number of outstanding shares of the Registrant&#8217;s Common Stock, as applicable.</span></div></div></ix:nonNumeric></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Represents the additional shares of Common Stock that were reserved for future issuance under the 2022 Plan on January 1, 2025, pursuant to an evergreen provision contained in the 2022 Plan. Pursuant to such provision, the number of shares reserved for issuance under the 2022 Plan will automatically increase on January 1 of each year for a period of 10 years, beginning on January 1, 2023 and ending on (and including) January 1, 2032, in an amount equal to four percent (4%) of the total number of shares of the Registrant&#8217;s Common Stock outstanding on December 31 of the preceding calendar year; provided, however, that the Company&#8217;s board of directors may act prior to January 1st of a given year to provide that the increase for such year will be a lesser number of shares of Common Stock.  </span></div></div></ix:nonNumeric></div>
  <div><ix:continuation id="F_6b2582e7-67ce-4e0d-9389-232d0941d60e_1" continuedAt="F_6b2582e7-67ce-4e0d-9389-232d0941d60e_2"><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(3)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Represents </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">the additional shares of Common Stock that were reserved for future issuance under the 2022 ESPP on January 1, 2025, pursuant to an evergreen provision contained in the 2022 ESPP. Pursuant to such </span></div></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <div style="font-size:10pt;font-family:Arial;"><ix:continuation id="F_6b2582e7-67ce-4e0d-9389-232d0941d60e_2" continuedAt="F_6b2582e7-67ce-4e0d-9389-232d0941d60e_3"><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7521786492374725%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">provision, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">the number of shares reserved for issuance under the 2022 ESPP will automatically increase on January 1 of each year for a period of 10 years, beginning on January 1, 2023 and continuing through (and including) January 1, 2032, by the lesser of (i) one percent (1%) of the total number of shares of the Registrant&#8217;s Common Stock outstanding on December 31st of the preceding calendar year, and (ii) 561,000 shares of Common Stock. Notwithstanding the foregoing, the Company&#8217;s board of directors may act prior to January 1st of a given year to provide that there will be no January 1st increase in the share reserve for such calendar year or that the increase in the share reserve for such calendar year will be a lesser number of shares of Common Stock than would otherwise occur pursuant to the preceding sentence.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">  </span></div></div></ix:continuation></div>
  <div><ix:continuation id="F_f0bef5c5-bc81-4358-8e44-e3b1d3f430bf_1" continuedAt="F_f0bef5c5-bc81-4358-8e44-e3b1d3f430bf_2"><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(4)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Estimated in accordance with Rules 457(c) and 457(h) of the Securities Act solely for the purpose of calculating the registration fee. The offering price per share and the aggregate offering price are based upon $1.39, which is the average of the high and low selling prices per share of the Registrant&#8217;s Common Stock on March 18, 2025 as reported on the Nasdaq Global Select Market.</span></div></div></ix:continuation></div>
  <div style="font-size:10pt;font-family:Arial;"><ix:continuation id="F_6b2582e7-67ce-4e0d-9389-232d0941d60e_3"><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(5)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Estimated in accordance with Rules 457(c) and 457(h) of the Securities Act solely for the purpose of calculating the registration fee. The offering price per share and the aggregate offering price are based upon $1.18 which is the average of the high and low selling prices per share of the Registrant&#8217;s Common Stock on March 18, 2025 as reported on the Nasdaq Global Select Market multiplied by 85%, which is the percentage of the price per shar</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">e applicable to purchases under the 2022 ESPP.</span></div></div><div><ix:continuation id="F_f0bef5c5-bc81-4358-8e44-e3b1d3f430bf_2"><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(6)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Each share of Common Stock registered hereunder includes an associated Series A Junior Participating Preferred Stock Purchase Right. Until the occurrence of certain prescribed events, none of which has occurred, the Series A Junior Participating Preferred Stock Purchase Rights are not exercisable, are evidenced by certificates representing the Common Stock, and may be transferred only with the Common Stock. No separate consideration is payable for the Series A Junior Participating Preferred Stock.</span><span style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"></span></div></div></ix:continuation></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>img51266987_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img51266987_0.jpg
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M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# __
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M-2T"#L(*TS!Y#$G6;YB\L6DO8F;?DGG%-NG,3Z)$PR9:Q B8R#PO241DMR@
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MA/C?@;C?&6"&P/B>DXGBK7+DGK''4B%;0C28F$FQ6:<@]0; 4BCA-J0"%'8
M OL#Q'7I4%LM]L0INWLH90LS(2) G9&$YKSUG#/50S5YPN-5<:JG;*&UOK*U
M)03,@$XXG$SQ/'A'=FN_&*0O/ZG/[,-_]?N'_P"J6+4<ZI?557ET>HJ'/[!O
MV^-?153[]B$=^ /Z<O$/^<;BKZ5,=+[E/ZPTGED>^3%P?:!^QW,'T=4_$.Q6
M@TY$:UL&B"#1!$\_U/GVD<-_-XH/XXLNEMU;^L"?)(_.B[+T>'V0O?2%3ZK4
M93^DR_U\<ROJGQ7]*K#KU]&OUFL\FGWYB._25_,F7?WU[^SMP\3J>XJ1@T00
M:((XC?[K XVHUQR':7B4?6J-5YZW3SU90B2;:(KT8YEI!4QSB!2]+5H;;?VC
MKAJ'VZ6G74NF3;:"H\P$S'I6:U5=]N]+9:!)56U=0VR@ 3FIQ00G#G,2/.3.
M=IWDKG_-/(6T"H:6RUD.RW4R!MQ.SC)*14+ 11 $1V+&PJ;=N4 V#9/P  \-
M)K>ZYV[WAZK6>FXX3S3,_ ,.Y&ROIAE:AT[TXMN7J9/]6HJ)M&&U6ZD)F.5Q
M4U\ZH^URCXTY#XBYEF<&Y2/#JW*#KM'L[Q2"=*/(L\;D"I1%RA01<*HHG.JG
M%S*1%@$H="Q3%]VOF]6:JL=9YC5[O6[J58&8Z20H8\Q$<VF.I-BU2RT,T9>#
MOF!?>:^$3N*)9><95T9G#>;4 9XB1X8=N],#RH#*G#RX\;9V0\^T\:;DLG")
M+K^8Z7QGD!5W/5\Y"&'J!M$S99!F&W@4A4P^YI@=*KQY_8U4#A^&IU?DJF?
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MN1>3V!-/E95T=3F:J;W;A>ZA;X)&/4@]4UMX"E!4)827.- CED\9@W%XT=-
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MS9LVV.^K+-"[_6!ZQ0*5'F!V]R.74OL]:IZ44R;AFNW_ /*%$#SAA:7F4D[
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M_G(S!>[,T5ZNHOS.M.NT(1-,1$?VI*(;HE+[MM)EF&N-SO=15SF%NJ([I/\
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M$8<"1&T3651 4&B",3LF\$^'.9[M*9'ROQLQ'D&]S;=BUEK7::A&RTU(-XQ
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M_=Q[V*B'9I^R[X5_4U'?CF9TW63OJQ1^1^Z8UV.TE]N>9?I _%MQUEWDNYQ
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M-G;M)(QDB',45 */3OL.T.AIPMET)/5@R)EAWXLC5<*)%8FWK=;%:M)4E!4
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M,R.4A/\ 5J:2$C@G(%1YRH^ 1>]V%=/+?D_1:DS"EL?+5[*JEUPCI;A4I#*
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MUS->*B_WQY51=ZIPK=<( *UG:2$@ ;-@ '$(YWKL1Y$>!$"@(B(  !N(B.P
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MD ?V1O#QU@^F]Q\PS2RE1DV]-!_&$O5W8:?MK9-.;=![FZTDJJ[<$U20!,_
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M6KK&B.3JU)CK?NFYO3X\]OSE/DLKY)C*-L53]9KIU!#J6L5W3+4(E% H_AK
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M^F9)X#HTN_7>F(2ULLB4JA4K5-5U"2*2PTPJ1GZ44[;$>'0*H8""J!@*!S
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M4H5W8I0]P:RXZAYL)GYVY^3_ "87=/8W[/J4A/\ #M(9<?7?[Z/3_C=]U/\
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MF31!D?&MA6,9R6,0$)*+9BB](1(  R<16^R9RM#/\84FZ''%%:FP-J%=(DH
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M,9W^BY(@SF3F,?W*KW:+,0PE,#ZL33*::[" AL!E&8 /WATKE"^NDK&JEO\
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M3F?_ '=B;^]+3K,]&OT%9SH_.A9_25?.N7/)U/J,PY/J;HJX@T00:((XE?\
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M-<\TI31<JJF++B8]PQLX(7P,@E79=1488ARB(;L%&I@$PF =_'7N63.5^L1
MHWU%B?B*Z23^*<!W)1%NI_9LTFU60M>9+6RFZ%,A4-#JGT_[5$E*EQ.!P2 $
MI80V_P  O4NX(SO,5[%_+VKL^.&0YIRVB8O(;*06E,*STHX-Y+9&2DWA0E:
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M2<$J 2)@DX@&>$L!P\<A$/=FGLPYXROJ+3:@ZCABT9>LF^_-;S2ENN!"DI2
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M0W_T1FKXP&#V"&H)RI5>9Y@I*B<@EY'>F ? 8M?[0%A_B/1_,%H"2M;MLJ
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M,D5#KC!,Y?I&E[OY83$RZ"F5X";@K$T.*;F"F8><;*%\#$6BW[9^D<OWRG0
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MSJ,K>\DL(X.E9T_59*+M;'5V3$4?F^;6%!Z] XD63,=(Q]9GDQ6:$4SE'F)
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M<PV2MRU?:S+]R245]%4N,. X$*;64'OD3')'.M=B/'@T01-R]1G]J?ECZO\
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M]0B3X8C@@ 7Y1BB(%U.6DK##%%5)8>0\GK$XI"QP'V:$>"<56>D*NETNF9[
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3#1!!H@@T00:((-$$&B"#1!'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>img51266987_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img51266987_1.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  = :P# 2(  A$! Q$!_\0
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MY,$^+W_9X'C_ /\ 5+_L_P!?T@5_-_\ \&OG_)@GQ>_[/ \?_P#JE_V?Z_I
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M//\ AI'_ (4I_P 70_X5;_PB_P#PAG_"X?C1XF^$/_(E?\+%\1?\)%_PCO\
MPCO_  D/_(VZ%_:_VS^R?^)9]G_M.?\ T@*_C_\ ^"O/_*?;_@F!_P!V5?\
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M+>++R".PU#4X&T?4/%/@#6;_ ,/7$ES'>W>@7.F76I:?I.HS76E67\<_P ^
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MU/5=)MY_"GB74M4\)ZOX^\$>'H]$U3QNOB'2_P"S#_@O9_RB<_:M_P"Z%_\
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MWC=QCSQY:BBHSB?C-'PZSKPI\(OII\"YZI3Q62XWP+IX7'?5YX:CF^65>/\
M,JF6YOA:<YU.7#YAA)4ZRIQK5OJ]5U<)4JRK8>K;^J#]H7XK_P#"AO@%\<?C
ME_8'_"5?\*9^#_Q+^*__  B_]J?V'_PDG_"N_!>M^+_[ _MO^SM8_L?^V/['
M_L[^U/[(U3^S_M'VO^SK[R?LTO\ &?\ L\_L]?\ !0/_ (.$?^%C_%K]H;]J
MK_A57[.?P^\83:!X0\-Z)X937_ %M\4;3[1XEMO#'A#X&:)XU\%VO_% ^!?B
M=<6%S\9?B/K^L_$:[T77_"_@^'Q#\08T\47O@S^S#]H7X4?\+Y^ 7QQ^!O\
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MZAK#>%M3UFW\/7$GBFTLM(U^;3-:U+3_ !#IVG77AW5?B?\ X)8?\$O/"?\
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M;_PE'_"9_P#"GOC1XF^+W_(Z_P#"Q?#O_"._\)%_PD7_  CW_(I:[_9'V/\
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M?8X/+\_R?&XNMR5*GLL+A<QP]?$5?9TH5*M3V=*G.?)2A.I*W+"$I-)_@_\
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M$/L\'..8X;B#/<NGDV,R^CFU6E5S:CB\/2^K8"K0HX7&4GA\/4I8=X<^#_\
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MG://\2?"WQ<\):CIVL?&/4=&\2^(/$/C;3?"MOK]CK_C34]<D;6-;BEU._\
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M%%A%I&J7TW@_PK\+?B)X^\::W=V,NC_V'_PC=MXCU;5XO#NCZU9WW[85YO\
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MP^*GB+6/&'Q=\7^"_AQ<^"/['_X17_A9.DZYX)\.>%];\=ZUX\\;7WBCP?\
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M@_3OC5IW@#5_%'BGX?\ BJXU+2O^$&\7^$V?4-8TSQ)X(O?]""OQ/_X*G_\
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MF&%S"CB<4J<(YSC<QP6!AE.%Q4JDX5J6!_DO_P"#KC_FPO\ [NC_ /?=*_L
MK\?_ /@JY_P2C_X>=_\ "A?^+]?\*0_X4A_PM+_FEO\ PLK_ (2?_A97_"NO
M^JB^ /[%_L7_ (0#_J+?VC_:W_+A]@_TW]@*[<IR[&X;B;BS,*]'DP>9_P!A
M?4:WM*4O;_4LOJ4,3^[A4E5I^SJR4?WT*?/?FI\\;L^6\0>->&<\\#?H\\'9
M7F?UKB/@;_B+/^M.7?4\PH?V7_K-Q?@LTR/_ &O$82C@,;]=P%&I7_X3L5B_
MJW+[+%_5ZSC397\6_P#P3E^$'PS^/O\ P6J_X*X_!WXQ>#='\?\ PT\?Z/\
MMM:'XL\)ZY'*UEJ5DW[:OPNNK:>"YM9K;4=)UC2=1MK/6?#WB'1KS3]?\,Z_
MI^F>(/#VIZ9K>F6%_;?VD5^/_P"R'_P2C_X94_;[_:@_;C_X7U_PGG_#2/\
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MP03_ .43G[*7_==/_6D_C%7V!^WM^RC_ ,-O_LG?%;]E[_A/?^%8_P#"SO\
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M(+_Q7'_"+?\ ":?V'_PA?Q*\'?$/_D6?^$C\)_VE_:7_  B?]D?\C!I_V/\
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M;Q3X6L[^WB\?^,O _P ,_'_PO\8:UXAU#Q[J"ZBWZ$?\&H__ #?I_P!VN?\
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M-'^*/@NU:R\)^ O"=EXR\$ZEHN@>#] O=#T[^Y#]H7X4?\+Y^ 7QQ^!O]O\
M_"*_\+F^#_Q+^%'_  E']E_VY_PC?_"Q/!>M^$/[?_L3^T='_MC^Q_[8_M'^
MR_[7TO\ M#[/]D_M&Q\[[3%^8_\ P3=_X(H_LZ_\$]M?'Q6D\1ZQ\=_VA6T?
M4-#M?B=XLT'2O#V@>";+4;W6HK^?X5> K:XUV?P;K'B#PM?Z;X7\5>(=9\8^
M,]?O+*PU>T\-:GX1\->,_%GA;4_V8KQ>$L@Q678/-WF="CA9YWF&*QLLLP]5
M3HX##XE.*PJJ4>2FY1C*4&Z#Y%3C2Y)734?T_P"D3XNY%QEQ+X<4^!LVS+/:
M'A9P=D'#5#CO.<!4PN9<69ODU2%:>?U,#F3Q&,6'K5Z-+%0I9O#ZU4QE?'O$
MT'"<9U?RO_9!_8I_;>_9HUKX-^'O&G_!2/\ X71^SG\(/!]MX!L_@%_PQY\(
M_AU_:WA/P]X N_!7@'2?^%IZ3XKU[QU8_P#"'W4?AS7/MTL^IZEX@_X1[^S-
M:O)X]6O[L\?=?L'_ /!0KPUXE^(W_"C?^"J__"G?A;XO^,'QH^*_A?X7_P##
M#/P1^(/_  A'_"Z?BSXS^+VMZ!_PFOB_QA/XB\2_9/$7C?5_^)IJ/V;S]_\
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)ZM?%5:U>I__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Mar. 25, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001880438<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">AN2 Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">S-8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Mar. 25, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock, $0.00001 par value per share, reserved for issuance pursuant to the Registrant's 2022 Equity Incentive Plan, together with the associated Series A Junior Participating Preferred Stock Purchase Rights<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">1,196,785<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">1.39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 1,663,531.15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 254.69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text"><div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this Registration Statement shall also cover any additional shares of Common Stock (&#8220;Common Stock&#8221;) of AN2 Therapeutics, Inc. (the &#8220;Registrant&#8221;) that become issuable under the Registrant&#8217;s 2022 Equity Incentive Plan (the &#8220;2022 Plan&#8221;) and the Registrant&#8217;s 2022 Employee Stock Purchase Plan (the &#8220;2022 ESPP&#8221;) by reason of any stock dividend, stock split, recapitalizations, or other similar transaction effected without receipt of consideration that results in an increase to the number of outstanding shares of the Registrant&#8217;s Common Stock, as applicable.</span></div></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Represents the additional shares of Common Stock that were reserved for future issuance under the 2022 Plan on January 1, 2025, pursuant to an evergreen provision contained in the 2022 Plan. Pursuant to such provision, the number of shares reserved for issuance under the 2022 Plan will automatically increase on January 1 of each year for a period of 10 years, beginning on January 1, 2023 and ending on (and including) January 1, 2032, in an amount equal to four percent (4%) of the total number of shares of the Registrant&#8217;s Common Stock outstanding on December 31 of the preceding calendar year; provided, however, that the Company&#8217;s board of directors may act prior to January 1st of a given year to provide that the increase for such year will be a lesser number of shares of Common Stock.  </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(4)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Estimated in accordance with Rules 457(c) and 457(h) of the Securities Act solely for the purpose of calculating the registration fee. The offering price per share and the aggregate offering price are based upon $1.39, which is the average of the high and low selling prices per share of the Registrant&#8217;s Common Stock on March 18, 2025 as reported on the Nasdaq Global Select Market.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(6)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Each share of Common Stock registered hereunder includes an associated Series A Junior Participating Preferred Stock Purchase Right. Until the occurrence of certain prescribed events, none of which has occurred, the Series A Junior Participating Preferred Stock Purchase Rights are not exercisable, are evidenced by certificates representing the Common Stock, and may be transferred only with the Common Stock. No separate consideration is payable for the Series A Junior Participating Preferred Stock.</span><span style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"></span></div></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock, $0.00001 par value per share, reserved for future issuance pursuant to the Registrant's 2022 Employee Stock Purchase Plan, together with the associated Series A Junior Participating Preferred Stock Purchase Rights<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">299,196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">1.18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 353,051.28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 54.05<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text"><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this Registration Statement shall also cover any additional shares of Common Stock (&#8220;Common Stock&#8221;) of AN2 Therapeutics, Inc. (the &#8220;Registrant&#8221;) that become issuable under the Registrant&#8217;s 2022 Equity Incentive Plan (the &#8220;2022 Plan&#8221;) and the Registrant&#8217;s 2022 Employee Stock Purchase Plan (the &#8220;2022 ESPP&#8221;) by reason of any stock dividend, stock split, recapitalizations, or other similar transaction effected without receipt of consideration that results in an increase to the number of outstanding shares of the Registrant&#8217;s Common Stock, as applicable.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(3)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Represents </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">the additional shares of Common Stock that were reserved for future issuance under the 2022 ESPP on January 1, 2025, pursuant to an evergreen provision contained in the 2022 ESPP. Pursuant to such </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7521786492374725%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">provision, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">the number of shares reserved for issuance under the 2022 ESPP will automatically increase on January 1 of each year for a period of 10 years, beginning on January 1, 2023 and continuing through (and including) January 1, 2032, by the lesser of (i) one percent (1%) of the total number of shares of the Registrant&#8217;s Common Stock outstanding on December 31st of the preceding calendar year, and (ii) 561,000 shares of Common Stock. Notwithstanding the foregoing, the Company&#8217;s board of directors may act prior to January 1st of a given year to provide that there will be no January 1st increase in the share reserve for such calendar year or that the increase in the share reserve for such calendar year will be a lesser number of shares of Common Stock than would otherwise occur pursuant to the preceding sentence.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">  </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(5)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Estimated in accordance with Rules 457(c) and 457(h) of the Securities Act solely for the purpose of calculating the registration fee. The offering price per share and the aggregate offering price are based upon $1.18 which is the average of the high and low selling prices per share of the Registrant&#8217;s Common Stock on March 18, 2025 as reported on the Nasdaq Global Select Market multiplied by 85%, which is the percentage of the price per shar</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">e applicable to purchases under the 2022 ESPP.</span></div></div><div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(6)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Each share of Common Stock registered hereunder includes an associated Series A Junior Participating Preferred Stock Purchase Right. Until the occurrence of certain prescribed events, none of which has occurred, the Series A Junior Participating Preferred Stock Purchase Rights are not exercisable, are evidenced by certificates representing the Common Stock, and may be transferred only with the Common Stock. No separate consideration is payable for the Series A Junior Participating Preferred Stock.</span><span style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"></span></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Mar. 25, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 2,016,582.43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">308.74<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 308.74<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( &:#>5I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( &:#>5JM=T4,[@   "L"   1
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MM5II ,,X?<D3$L/<@HL(2W@4R]9<X%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A
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MH__ECL9H6;R6Q:O\!F^RH%]/>@VM%##YNPNL-AIV&YF#/),YB2# ^J1*$*^
MP_?O^F/W@P5ST&(.;.[A C(E2(I660PG] 7.78!V"]=U^].I.QQ,+3S#EF=H
M-=O"D4I-E"FT)@RZ:.P&#VL//2<@2 Z%HI&\TZE%/0O9J"4;68W-=X.>SWDG
MDUVZN[>59MP"C.TN_T[4+8PW#*P8DQ9C8J\# %J>$KJGZB:'W6'Y\_YQ];1:
M?T*/R^6N"\FYZ@&FG>J/\T@SB5(X:$>W-]'U%G6+J@/%\ZHM[+G23:8:)KJK
M@S ;]/J!<W4)3*=I_Q/A7U!+ P04    " !F@WE:7 #X1<4(   L)@  &
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MH TJ: //?7 *VB%@@Z\ ;%@!&S;J[&<IV=3(>Z5S&Z_95*CH$,1F)G,16]D
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M#I+ P5&<Q3%#Q= LU/>0*](U$U&DZ)R(RS@DT=O9B[5+D=LO-P+I\*OW ?N
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M B#I +Z?:S3DY0/]PJCZ@=C-OP%02P,$%     @ 9H-Y6JU""H\5 @  X00
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M              "  > !  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%
M  @ 9H-Y6N@/D[M% @  ,P8  !@              ("!(0@  'AL+W=O<FMS
M:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( &:#>5I< /A%Q0@  "PF   8
M              " @9P*  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"
M% ,4    " !F@WE:K4(*CQ4"  #A!   &               @(&7$P  >&PO
M=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ 9H-Y6BK&(&0) P
M&Q    T              ( !XA4  'AL+W-T>6QE<RYX;6Q02P$"% ,4
M" !F@WE:EXJ[',     3 @  "P              @ $6&0  7W)E;',O+G)E
M;'-02P$"% ,4    " !F@WE:4G%OM5T!  !( P  #P              @ '_
M&0  >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ 9H-Y6KMLZNRZ    &@,
M !H              ( !B1L  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS
M4$L! A0#%     @ 9H-Y6J;\2ELC 0  WP0  !,              ( !>QP
J %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      L "P#* @  SQT

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>18</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="antx_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="antx_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="antx_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="antx_exfilingfees.htm">antx_exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/ffd/2024q2</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "antx_exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "antx_exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
     ]
    }
   },
   "keyStandard": 18,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/ffd/2024q2": 1,
    "http://xbrl.sec.gov/dei/2024": 1
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024q2": 26,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_aeae6f8e-7bd1-4f27-8e53-c9f1212753ea",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "antx_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_aeae6f8e-7bd1-4f27-8e53-c9f1212753ea",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "antx_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "C_7c0d364f-6ff9-440f-8ce9-ccdd5b0de136",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "antx_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7c0d364f-6ff9-440f-8ce9-ccdd5b0de136",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "antx_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "C_aeae6f8e-7bd1-4f27-8e53-c9f1212753ea",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "antx_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_aeae6f8e-7bd1-4f27-8e53-c9f1212753ea",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "antx_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0000950170-25-044432-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-25-044432-xbrl.zip
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M1A-6OS&LOC>(<C'=_V%O,*K&Z?[_ %!+ 0(4 Q0    ( &:#>5H=0JI["18
M (89 0 5              "  0    !A;G1X7V5X9FEL:6YG9F5E<RYH=&U0
52P4&      $  0!#    /!8

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>antx_exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
      xlink:type="simple"/>
    <context id="C_aeae6f8e-7bd1-4f27-8e53-c9f1212753ea">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001880438</identifier>
        </entity>
        <period>
            <startDate>2025-03-25</startDate>
            <endDate>2025-03-25</endDate>
        </period>
    </context>
    <context id="C_24f95288-ebb5-4f77-8b9e-c8566295825f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001880438</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-25</startDate>
            <endDate>2025-03-25</endDate>
        </period>
    </context>
    <context id="C_7c0d364f-6ff9-440f-8ce9-ccdd5b0de136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001880438</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-25</startDate>
            <endDate>2025-03-25</endDate>
        </period>
    </context>
    <unit id="U_pure">
        <measure>pure</measure>
    </unit>
    <unit id="U_shares">
        <measure>shares</measure>
    </unit>
    <unit id="U_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <ffd:FeeExhibitTp
      contextRef="C_aeae6f8e-7bd1-4f27-8e53-c9f1212753ea"
      id="F_f3ca39c5-a237-4c27-aac5-b6c721d1dabc">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey
      contextRef="C_aeae6f8e-7bd1-4f27-8e53-c9f1212753ea"
      id="F_a1ca55e2-2c14-4d77-a29f-afb7009ec5d3">0001880438</dei:EntityCentralIndexKey>
    <ffd:FormTp
      contextRef="C_aeae6f8e-7bd1-4f27-8e53-c9f1212753ea"
      id="F_14de71ab-2c53-4ee1-bbe1-eff6ea70aed1">S-8</ffd:FormTp>
    <ffd:SubmissnTp
      contextRef="C_aeae6f8e-7bd1-4f27-8e53-c9f1212753ea"
      id="F_770b0d85-33b6-45c6-bf71-399aaaf4f8ed">S-8</ffd:SubmissnTp>
    <dei:EntityRegistrantName
      contextRef="C_aeae6f8e-7bd1-4f27-8e53-c9f1212753ea"
      id="F_09b194a9-ef76-474e-9f42-deab474b8f76">AN2 Therapeutics, Inc.</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg
      contextRef="C_7c0d364f-6ff9-440f-8ce9-ccdd5b0de136"
      id="F_3328d499-745e-4965-bb1c-b9906e3e41ea">false</ffd:PrevslyPdFlg>
    <ffd:PrevslyPdFlg
      contextRef="C_24f95288-ebb5-4f77-8b9e-c8566295825f"
      id="F_cdd1c862-e7ec-45aa-82ed-166c1dfb2c8b">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp
      contextRef="C_7c0d364f-6ff9-440f-8ce9-ccdd5b0de136"
      id="F_f8d4bbc0-a4da-4957-b412-69e0606d07e1">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl
      contextRef="C_7c0d364f-6ff9-440f-8ce9-ccdd5b0de136"
      id="F_50da937c-a949-4f67-974a-55b02275786f">Common Stock, $0.00001 par value per share, reserved for issuance pursuant to the Registrant's 2022 Equity Incentive Plan, together with the associated Series A Junior Participating Preferred Stock Purchase Rights</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg
      contextRef="C_7c0d364f-6ff9-440f-8ce9-ccdd5b0de136"
      id="F_f1bcf6c3-770a-4cea-9ef3-3acb91cfe6cc">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="C_7c0d364f-6ff9-440f-8ce9-ccdd5b0de136"
      decimals="0"
      id="F_b0af3dce-461c-4279-99c4-21dbc1714536"
      unitRef="U_shares">1196785</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="C_7c0d364f-6ff9-440f-8ce9-ccdd5b0de136"
      decimals="2"
      id="F_8372978f-9194-4ace-bf28-4a5abf7d2843"
      unitRef="U_USD">1.39</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="C_7c0d364f-6ff9-440f-8ce9-ccdd5b0de136"
      decimals="2"
      id="F_9d1a46f9-5744-4ecb-8231-d6d48e1823ea"
      unitRef="U_USD">1663531.15</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="C_7c0d364f-6ff9-440f-8ce9-ccdd5b0de136"
      decimals="7"
      id="F_cb14a41d-ff4f-4b21-a0d9-da0c3dbf4368"
      unitRef="U_pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="C_7c0d364f-6ff9-440f-8ce9-ccdd5b0de136"
      decimals="2"
      id="F_b5e1cd74-d330-49aa-8d45-27b92227c476"
      unitRef="U_USD">254.69</ffd:FeeAmt>
    <ffd:OfferingSctyTp
      contextRef="C_24f95288-ebb5-4f77-8b9e-c8566295825f"
      id="F_96c88e93-68ed-40f8-93a7-cd94e78c781b">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl
      contextRef="C_24f95288-ebb5-4f77-8b9e-c8566295825f"
      id="F_710b6d4d-6d5e-435c-b18d-09bc2e7b7ae2">Common Stock, $0.00001 par value per share, reserved for future issuance pursuant to the Registrant's 2022 Employee Stock Purchase Plan, together with the associated Series A Junior Participating Preferred Stock Purchase Rights</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg
      contextRef="C_24f95288-ebb5-4f77-8b9e-c8566295825f"
      id="F_8a8185c5-1281-45e6-a23b-014e19c118f5">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="C_24f95288-ebb5-4f77-8b9e-c8566295825f"
      decimals="0"
      id="F_417ce742-dc76-4e05-8c55-c7f87b74dd83"
      unitRef="U_shares">299196</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="C_24f95288-ebb5-4f77-8b9e-c8566295825f"
      decimals="2"
      id="F_cbfa6098-cd4b-4824-8167-d70df77cfffe"
      unitRef="U_USD">1.18</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="C_24f95288-ebb5-4f77-8b9e-c8566295825f"
      decimals="2"
      id="F_2458f3e6-5713-4a5c-b925-97eff79fb72b"
      unitRef="U_USD">353051.28</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="C_24f95288-ebb5-4f77-8b9e-c8566295825f"
      decimals="7"
      id="F_32983a2d-0a55-4b32-8520-2260128f0cfe"
      unitRef="U_pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="C_24f95288-ebb5-4f77-8b9e-c8566295825f"
      decimals="2"
      id="F_74e297a7-fa49-465d-8abf-e7fa7e2a86cd"
      unitRef="U_USD">54.05</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="C_aeae6f8e-7bd1-4f27-8e53-c9f1212753ea"
      decimals="2"
      id="F_e428ffce-3131-49bc-b082-f37ef2993c68"
      unitRef="U_USD">2016582.43</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="C_aeae6f8e-7bd1-4f27-8e53-c9f1212753ea"
      decimals="2"
      id="F_7341a95d-f539-42b3-b966-580dd7fbb2c6"
      unitRef="U_USD">308.74</ffd:TtlFeeAmt>
    <ffd:NetFeeAmt
      contextRef="C_aeae6f8e-7bd1-4f27-8e53-c9f1212753ea"
      decimals="2"
      id="F_69c2e79e-9344-47c2-804b-42b67d176b78"
      unitRef="U_USD">308.74</ffd:NetFeeAmt>
    <ffd:OfferingNote
      contextRef="C_7c0d364f-6ff9-440f-8ce9-ccdd5b0de136"
      id="F_f0bef5c5-bc81-4358-8e44-e3b1d3f430bf">&lt;div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(1)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), this Registration Statement shall also cover any additional shares of Common Stock (&#x201c;Common Stock&#x201d;) of AN2 Therapeutics, Inc. (the &#x201c;Registrant&#x201d;) that become issuable under the Registrant&#x2019;s 2022 Equity Incentive Plan (the &#x201c;2022 Plan&#x201d;) and the Registrant&#x2019;s 2022 Employee Stock Purchase Plan (the &#x201c;2022 ESPP&#x201d;) by reason of any stock dividend, stock split, recapitalizations, or other similar transaction effected without receipt of consideration that results in an increase to the number of outstanding shares of the Registrant&#x2019;s Common Stock, as applicable.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(2)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;Represents the additional shares of Common Stock that were reserved for future issuance under the 2022 Plan on January 1, 2025, pursuant to an evergreen provision contained in the 2022 Plan. Pursuant to such provision, the number of shares reserved for issuance under the 2022 Plan will automatically increase on January 1 of each year for a period of 10 years, beginning on January 1, 2023 and ending on (and including) January 1, 2032, in an amount equal to four percent (4%) of the total number of shares of the Registrant&#x2019;s Common Stock outstanding on December 31 of the preceding calendar year; provided, however, that the Company&#x2019;s board of directors may act prior to January 1st of a given year to provide that the increase for such year will be a lesser number of shares of Common Stock.  &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(4)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;Estimated in accordance with Rules 457(c) and 457(h) of the Securities Act solely for the purpose of calculating the registration fee. The offering price per share and the aggregate offering price are based upon $1.39, which is the average of the high and low selling prices per share of the Registrant&#x2019;s Common Stock on March 18, 2025 as reported on the Nasdaq Global Select Market.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(6)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;Each share of Common Stock registered hereunder includes an associated Series A Junior Participating Preferred Stock Purchase Right. Until the occurrence of certain prescribed events, none of which has occurred, the Series A Junior Participating Preferred Stock Purchase Rights are not exercisable, are evidenced by certificates representing the Common Stock, and may be transferred only with the Common Stock. No separate consideration is payable for the Series A Junior Participating Preferred Stock.&lt;/span&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;</ffd:OfferingNote>
    <ffd:OfferingNote
      contextRef="C_24f95288-ebb5-4f77-8b9e-c8566295825f"
      id="F_6b2582e7-67ce-4e0d-9389-232d0941d60e">&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(1)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), this Registration Statement shall also cover any additional shares of Common Stock (&#x201c;Common Stock&#x201d;) of AN2 Therapeutics, Inc. (the &#x201c;Registrant&#x201d;) that become issuable under the Registrant&#x2019;s 2022 Equity Incentive Plan (the &#x201c;2022 Plan&#x201d;) and the Registrant&#x2019;s 2022 Employee Stock Purchase Plan (the &#x201c;2022 ESPP&#x201d;) by reason of any stock dividend, stock split, recapitalizations, or other similar transaction effected without receipt of consideration that results in an increase to the number of outstanding shares of the Registrant&#x2019;s Common Stock, as applicable.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(3)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;Represents &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;the additional shares of Common Stock that were reserved for future issuance under the 2022 ESPP on January 1, 2025, pursuant to an evergreen provision contained in the 2022 ESPP. Pursuant to such &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7521786492374725%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;provision, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;the number of shares reserved for issuance under the 2022 ESPP will automatically increase on January 1 of each year for a period of 10 years, beginning on January 1, 2023 and continuing through (and including) January 1, 2032, by the lesser of (i) one percent (1%) of the total number of shares of the Registrant&#x2019;s Common Stock outstanding on December 31st of the preceding calendar year, and (ii) 561,000 shares of Common Stock. Notwithstanding the foregoing, the Company&#x2019;s board of directors may act prior to January 1st of a given year to provide that there will be no January 1st increase in the share reserve for such calendar year or that the increase in the share reserve for such calendar year will be a lesser number of shares of Common Stock than would otherwise occur pursuant to the preceding sentence.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(5)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;Estimated in accordance with Rules 457(c) and 457(h) of the Securities Act solely for the purpose of calculating the registration fee. The offering price per share and the aggregate offering price are based upon $1.18 which is the average of the high and low selling prices per share of the Registrant&#x2019;s Common Stock on March 18, 2025 as reported on the Nasdaq Global Select Market multiplied by 85%, which is the percentage of the price per shar&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;e applicable to purchases under the 2022 ESPP.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(6)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;Each share of Common Stock registered hereunder includes an associated Series A Junior Participating Preferred Stock Purchase Right. Until the occurrence of certain prescribed events, none of which has occurred, the Series A Junior Participating Preferred Stock Purchase Rights are not exercisable, are evidenced by certificates representing the Common Stock, and may be transferred only with the Common Stock. No separate consideration is payable for the Series A Junior Participating Preferred Stock.&lt;/span&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
